A. Eden Evins, MD, MPH; Corinne Cather, PhD; Sarah A. Pratt, PhD; et al.
free access
JAMA. 2014;311(2):145-154. doi:10.1001/jama.2013.285113
Jon O. Ebbert, MD, MSc; Dorothy K. Hatsukami, PhD; Ivana T. Croghan, PhD; et al.
free access
JAMA. 2014;311(2):155-163. doi:10.1001/jama.2013.283185
Ebberts and colleagues compare the efficacy and safety of varenicline and sustained-release bupropion vs varenicline alone in 506 adult cigarette smokers in a randomized, blinded, placebo-controlled, 12-week clinical trial (52-week follow-up) at 3 centers from October 2009 through April 2013.
Theodore R. Holford, PhD; Rafael Meza, PhD; Kenneth E. Warner, PhD; et al.
free access
has multimedia
has audio
JAMA. 2014;311(2):164-171. doi:10.1001/jama.2013.285112
Holford and coauthors used National Health Interview Surveys to assess cigarette smoking histories for the US adult population and model reductions in smoking-related mortality associated with implementation of tobacco control since 1964, when the first surgeon general鈥檚 report on smoking and health was released.
-
Podcast:
Tobacco Control and the Reduction in Smoking-Related Premature Deaths in the United States, 1964-2012
Benjamin Lê Cook, PhD, MPH; Geoff Ferris Wayne, MA; E. Nilay Kafali, PhD; et al.
free access
JAMA. 2014;311(2):172-182. doi:10.1001/jama.2013.284985
To examine associations between tobacco use and mental illness, Cook and coauthors used nationally representative surveys of noninstitutionalized US residents to compare trends in smoking rates between adults with and without mental illness and to compare rates of smoking cessation among adults with mental illness who did and did not receive mental health treatment.
Marie Ng, PhD; Michael K. Freeman, MPH; Thomas D. Fleming, BS; et al.
free access
has multimedia
JAMA. 2014;311(2):183-192. doi:10.1001/jama.2013.284692
Ng and coauthors estimated the prevalence of daily smoking by age and sex and the number of cigarettes per smoker per day for 187 countries from 1980 to 2012.